LON:ABTX

ABTX.L Share Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive ABTX News and Ratings via Email

Sign-up to receive the latest news and ratings for ABTX.L and its competitors with MarketBeat's FREE daily newsletter.

About ABTX.L

AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company's AquAdvantage Salmon.

Breezy Explainer: ISpA- All about public-private partnerships in space
October 14, 2021 | sg.finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Commercial Banking
Sub-Industry: N/A
Sector: Finance and Insurance
Current Symbol: LON:ABTX
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: aquabounty.com
Phone: +1-978-6486000
Employees: 598
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ABTX.L.

4.7 Community Rank

Outperform Votes
ABTX.L has received 76 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ABTX.L has received 32 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ABTX.L has received 70.37% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ABTX.L and other stocks. Vote “Outperform” if you believe ABTX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABTX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ABTX.L does not currently pay a dividend.
Dividend Growth
ABTX.L does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ABTX.L insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

ABTX.L (LON:ABTX) Frequently Asked Questions

What stocks does MarketBeat like better than ABTX.L?: Wall Street analysts have given ABTX.L a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ABTX.L wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are ABTX.L's key executives?: ABTX.L's management team includes the following people:
Ronald L. Stotish Ph.D., President, Chief Executive Officer, Executive Director (Age 67)
David A. Frank, Chief Financial Officer, Treasurer (Age 56)
Christopher Martin J.D., General Counsel, Corporate Secretary (Age 50)
Alejandro Rojas, Chief Operating Officer - AquaBounty Farms division (Age 55)
Richard J Clothier, Non-Executive Independent Chairman of the Board (Age 70)
Jack Anthony Bobo, Non-Executive Director (Age 51)
Rick L. Sterling CPA, Non-Executive Director (Age 53)
Richard L. Huber, Non-Executive Independent Director (Age 80)
Christine Thompson St.Clare, Non-Executive Independent Director (Age 66)
Who are some of ABTX.L's key competitors?: Some companies that are related to ABTX.L include 543656 (OIL.V) (OIL), Amerant Bancorp (AMTBB), Concordia Financial Group (CRDIY), iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), iPath Series B US Treasury 10-year Bear ETN (BTYS), iPath Series B US Treasury 10-year Bear ETN (BTYS), Ossiam Lux - Ossiam Shiller Barclays CAPE Europe Sector Value TR (CAPE), Southern Community Bancshares (SCBS), U.S. Century Bank (USCB) and Wavenet International (WAL).
View all of ABTX's competitors.
What is ABTX.L's stock symbol?: ABTX.L trades on the London Stock Exchange (LON) under the ticker symbol "ABTX."
How do I buy shares of ABTX.L?: Shares of ABTX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
How many employees does ABTX.L have?: ABTX.L employs 598 workers across the globe.
What is ABTX.L's official website?: The official website for ABTX.L is aquabounty.com.
Where are ABTX.L's headquarters?: ABTX.L is headquartered at 2 Clock Tower Pl Ste 395, MAYNARD, MA 01754-2539, United States.
How can I contact ABTX.L?: ABTX.L's mailing address is 2 Clock Tower Pl Ste 395, MAYNARD, MA 01754-2539, United States. The biotechnology company can be reached via phone at +1-978-6486000.

This page was last updated on 10/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.